Results 81 to 90 of about 461 (125)

Weight regain after cessation of medication for weight management: systematic review and meta-analysis.

BMJ
West S, Scragg J, Aveyard P, Oke JL, Willis L, Haffner SJP, Knight H, Wang D, Morrow S, Heath L, Jebb SA, Koutoukidis DA.   +11 more
europepmc   +1 more source

GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity. [PDF]

J Clin Invest
Cooper ME, van Raalte DH.
europepmc   +1 more source

Correction to "NN1213 - A Potent, Long-Acting, and Selective Analog of Human Amylin". [PDF]

J Med Chem
Dahl K, Raun K, Hansen JL, Poulsen C, de la Cour CD, Clausen TR, Hansen AMK, John LM, Plesner A, Sun G, Schlein M, Skyggebjerg RB, Kruse T.   +12 more
europepmc   +1 more source

The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats. [PDF]

EBioMedicine
Kuhre RE, Ballarín-González B, Brand CL, Glendorf T, Madsen KG, Hjøllund KR, Hogendorf WFJ, Ipsen DH, Lundh S, Kruse T, Petersen SB, Secher A, Vegge A, Raun K.   +13 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety. [PDF]

PLoS Med
Chao AM, Gilden A, Wadden TA.
europepmc   +1 more source

Obesity-Related Glomerulosclerosis-How Adiposity Damages the Kidneys. [PDF]

Int J Mol Sci
Zbrzeźniak-Suszczewicz J, Winiarska A, Perkowska-Ptasińska A, Stompór T.   +3 more
europepmc   +1 more source

Is pharmacotherapy ready to redefine the state of the art in obstructive sleep apnea care? [PDF]

Expert Opin Pharmacother
Johnston EK, Bird EM, Malhotra A, Harding CD.   +3 more
europepmc   +1 more source

Nutrient-Stimulated Hormone Therapies in Heart Failure: Targeting Cardiometabolic Burden Beyond Weight Reduction. [PDF]

Int J Heart Fail
Cho DH.
europepmc   +1 more source

Efficacy and safety of incretin co-agonists: Transformative advances in cardiometabolic healthcare. [PDF]

World J Cardiol
Bhat S, Fernandez CJ, Lakshmi V, Pappachan JM.   +3 more
europepmc   +1 more source

Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies. [PDF]

Medicines (Basel)
Ullah MI, Tamanna S.
europepmc   +1 more source